Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Milestone Pharmaceuticals Inc (NQ: MIST )

1.650 +0.080 (+5.10%)
Streaming Delayed Price Updated: 3:59 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 215,006
Open 1.570
Bid (Size) 1.600 (2)
Ask (Size) 1.660 (9)
Prev. Close 1.570
Today's Range 1.505 - 1.670
52wk Range 1.330 - 3.950
Shares Outstanding 53,149,778
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MIST Stock Earnings: Milestone Pharmaceuticals Misses EPS for Q4 2023
MIST stock results show that Milestone Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Milestone Pharmaceuticals: Q4 Earnings Insights
Via Benzinga

Performance

YTD
-8.33%
-8.33%
1 Month
-9.84%
-9.84%
3 Month
-5.17%
-5.17%
6 Month
-30.67%
-30.67%
1 Year
-54.42%
-54.42%

More News

Read More
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Milestone Pharmaceuticals (MIST) Stock Is Rising
Via Benzinga
Recap: Milestone Pharmaceuticals Q3 Earnings
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
MILESTONE ALERT: Bragar Eagel & Squire, P.C. is Investigating Milestone Pharmaceuticals Inc. on Behalf of Milestone Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST
Via NewMediaWire
Exposures Product Safety
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January
Via Benzinga
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A LEADING AND RANKED FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST
Via NewMediaWire
Exposures Product Safety
Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Rises Over 3%; US Home Prices Increase In October
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
ROSEN, A LEADING LAW FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST
From The Rosen Law Firm, P.A.
Via Business Wire
Why Is Heart Disease-Focused Milestone Pharmaceuticals Stock Plummeting Today?
Via Benzinga
Exposures Product Safety
Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.